PE CORP
S-8, 1999-12-02
LABORATORY ANALYTICAL INSTRUMENTS
Previous: MOORE MEDICAL CORP, 4, 1999-12-02
Next: PE CORP, S-8, 1999-12-02



                                                     Registration No. 333-
================================================================================

                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   ----------

                                    FORM S-8
                             REGISTRATION STATEMENT
                                      UNDER
                           THE SECURITIES ACT OF 1933

                                   ----------

                                 PE CORPORATION
             (Exact Name of Registrant as Specified in Its Charter)

                   Delaware                        06-1534213
         (State or Other Jurisdiction of       (I.R.S. Employer
         Incorporation or Organization)      Identification Number)

                                 761 MAIN AVENUE
                         NORWALK, CONNECTICUT 06859-0001
          (Address of Principal Executive Offices, including Zip Code)

                       PE CORPORATION/PE BIOSYSTEMS GROUP
                            1999 STOCK INCENTIVE PLAN
                            (Full Title of the Plan)

                                WILLIAM B. SAWCH
              Senior Vice President, General Counsel and Secretary
                                 PE CORPORATION
                                 761 Main Avenue
                         Norwalk, Connecticut 06859-0001
                                 (203) 762-1000
           (Name, Address, and Telephone Number of Agent for Service)

                         CALCULATION OF REGISTRATION FEE
<TABLE>
<CAPTION>
===================================================================================================================
                                                                Proposed
                                                                 Maximum         Proposed Maximum
                                            Amount to be    Offering Price Per   Aggregate Offering      Amount of
Title of Securities to be Registered          Registered         Share (1)           Price (1)       Registration Fee
===================================================================================================================
<S>                                           <C>                <C>                 <C>                <C>
PE Corporation - PE Biosystems Group          4,000,000          $80.0313             $320,125,200       $84,513
Common Stock, par value $.01 per share (2)
===================================================================================================================
</TABLE>

1.   Pursuant to Rule 457(h)(1) and Rule 457(c), the proposed maximum offering
     price per share and the registration fee are based upon the reported
     average of the high and low prices for the PE Corporation - PE Biosystems
     Group Common Stock (the "Common Stock") on the New York Stock Exchange on
     November 24, 1999. The maximum offering price per share is estimated
     solely for purposes of calculating the registration fee.
2.   This Registration Statement also pertains to rights to purchase Series A
     Participating Junior Preferred Stock, par value $.01 per share, of the
     Registrant (the "Rights"). Until the occurrence of certain prescribed
     events, the Rights are not exercisable, are evidenced by the certificates
     for Common Stock, and will be transferred along with and only with such
     securities. Thereafter, separate Rights certificates will be issued
     representing one Right for each share of Common Stock held, subject to
     adjustment pursuant to anti-dilution provisions.

================================================================================
<PAGE>


     The contents of the Registration Statement on Form S-8 filed by PE
Corporation (the "Company") (File No.: 333-82679) on July 12, 1999 with the
Securities and Exchange Commission pursuant to the Securities Act of 1933, as
amended, is hereby incorporated by reference in this Registration Statement.

                                     PART II

               INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

ITEM 8.    EXHIBITS.

     The following exhibits are filed as part of this Registration Statement:

     Exhibit 23(1) - Consent of PricewaterhouseCoopers LLP.

     Exhibit 24    - Power of Attorney (contained on the signature pages
                     hereof).



<PAGE>


                                   SIGNATURES

     Pursuant to the requirements of the Securities Act of 1933, the Company
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-8 and has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Norwalk, State of Connecticut, on December 2, 1999.

                                           PE CORPORATION

                                           By:    /s/ William B. Sawch
                                                ----------------------------
                                                William B. Sawch
                                                Senior Vice President, General
                                                Counsel and Secretary

                                POWER OF ATTORNEY

     We, the undersigned directors and officers of the Company, do hereby
constitute and appoint Dennis L. Winger and William B. Sawch, or either of them,
our true and lawful attorneys and agents, to do any and all acts and things in
our name and on our behalf in our capacities as directors and officers and to
execute any and all instruments for us and in our names in the capacities
indicated below, which said attorneys and agents, or either of them, may deem
necessary or advisable to enable said corporation to comply with the Securities
Act of 1933 and any rules, regulations and requirements of the Securities and
Exchange Commission, in connection with this Registration Statement, including
specifically, but without limitation, power and authority to sign for us or any
of us in our names in the capacities indicated below, any and all amendments
(including post-effective amendments) hereto and we do hereby ratify and confirm
all that said attorneys and agents, or either of them, shall do or cause to be
done by virtue hereof.

     Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons in the
capacities and on the dates indicated.

<TABLE>
<S>                                <C>                               <C>
      /s/ Tony L. White            Chairman of the Board,            December 2, 1999
- -----------------------------      President and Chief
Tony L. White                      Executive Officer
                                   (Principal Executive Officer)


    /s/ Dennis L. Winger           Senior Vice President and         December 2, 1999
- -----------------------------      Chief Financial Officer
Dennis L. Winger                   (Principal Financial Officer)





<PAGE>

      /s/ Vikram Jog               Corporate Controller              December 2, 1999
- -----------------------------      (Principal Accounting
Vikram Jog                         Officer)

   /s/ Richard H. Ayers            Director                          December 2, 1999
- -----------------------------
Richard H. Ayers

   /s/ Jean-Luc Belingard          Director                          December 2, 1999
- -----------------------------
Jean-Luc Belingard

                                   Director                                    , 1999
- -----------------------------
Robert H. Hayes

                                   Director                                    , 1999
- -----------------------------
Arnold J. Levine

   /s/ Theodore E. Martin          Director                          December 2, 1999
- -----------------------------
Theodore E. Martin

/s/ Georges C. St. Laurent, Jr.    Director                          December 2, 1999
- -----------------------------
Georges C. St. Laurent, Jr.


  /s/ Carolyn W. Slayman           Director                          December 2, 1999
- -----------------------------
Carolyn W. Slayman

    /s/ Orin R. Smith              Director                          December 2, 1999
- -----------------------------
Orin R. Smith

   /s/ James R. Tobin              Director                          December 2, 1999
- ---------------------------
James R. Tobin
</TABLE>


<PAGE>




                                  EXHIBIT INDEX

Exhibit No.                   Exhibit
- -----------                   -------

  23(1)        Consent of PricewaterhouseCoopers LLP




                       CONSENT OF INDEPENDENT ACCOUNTANTS

         We hereby consent to the incorporation by reference in this
Registration Statement on Form S-8 of our reports dated July 30, 1999 on the
combined financial statements of PE Biosystems Group, the combined financial
statements of Celera Genomics Group and the consolidated financial statements of
PE Corporation, which appear in the Annual Report to Stockholders of PE
Corporation, which is incorporated by reference in PE Corporation's Annual
Report on Form 10-K for the year ended June 30, 1999. We also consent to the
incorporation by reference of our reports dated July 30, 1999 relating to the
Financial Statement Schedules, which appear in such Annual Report on Form 10-K.


/s/ PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP

Stamford, Connecticut
November 29, 1999



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission